Clinical Trials Directory

Trials / Completed

CompletedNCT02896530

Arterial Thrombosis and Inflammatory Bowel Disease: a Series of 6 Cases and Literature Review

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
Fondation Hôpital Saint-Joseph · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Vascular complications in patients with inflammatory bowel disease (IBD), comprising mainly Crohn's disease (CD) and ulcerative colitis (UC), representing 2% extra-intestinal complications. In over 60% of cases, these vascular complications of deep venous thrombosis (DVT) or pulmonary embolism (PE). Several studies have shown that patients with IBD have a risk of venous thromboembolic disease (VTE) increased from 1.5 to 3.5. This risk is closely related to disease activity.

Detailed description

Vascular complications in patients with inflammatory bowel disease (IBD), comprising mainly Crohn's disease (CD) and ulcerative colitis (UC), representing 2% extra-intestinal complications. In over 60% of cases, these vascular complications of deep venous thrombosis (DVT) or pulmonary embolism (PE). Several studies have shown that patients with IBD have a risk of venous thromboembolic disease (VTE) increased from 1.5 to 3.5. This risk is closely related to disease activity. However, the association between IBD and arterial thromboembolic events such as cases of myocardial infarction, stroke, aortic thrombus, mesenteric ischemia, peripheral arterial disease and members senior, was described less and remains a subject of debate. These arterial complications occur in young subjects accountability of IBD remains debated, and no clear pathophysiology. Here the investigators describe a series of 6 cases of patients with IBD who developed severe arterial complications, and whose cause was retained digestive inflammatory underlying disease. This study is report of six (6) cases that will be described

Conditions

Interventions

TypeNameDescription
OTHERNo intervention. Description study

Timeline

Start date
2015-05-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2016-09-12
Last updated
2016-09-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02896530. Inclusion in this directory is not an endorsement.